Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Cowen & Co. Downgrades Imago BioSciences to Market Perform, Announces $36 Price Target

Cowen & Co. analyst Marc Frahm downgrades Imago BioSciences (NASDAQ:IMGO) from Outperform to Market Perform and announces $36 price target.
byBenzinga Newsdesk
November 22, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Cowen & Co. analyst Marc Frahm downgrades Imago BioSciences (NASDAQ:IMGO) from Outperform to Market Perform and announces $36 price target.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0